Reports Q2 revenue $6.15M, consensus $6.46M. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable Business-to-Business (“B2B”) customers, expanding gross margins, and reduced operating expenses, as compared to the same period last year,” stated Erez Raphael, CEO of Dario. “Of note, we increased our gross profit margin to 33.7% in the second quarter of 2023 compared to 18.4% in the second quarter of 2022. Our proforma gross margins increased to 51.5% in the second quarter of 2023, up significantly from 36.1% in the second quarter of 2022, while reducing our operating expense run rate by 13% over that period.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DRIO:
- DarioHealth Reports Second Quarter 2023 Financial and Operating Results
- DarioHealth expands agreement with large regional health
- DRIO Upcoming Earnings Report: What to Expect?
- DarioHealth price target lowered to $5.45 from $5.90 at Alliance Global
- DarioHealth price target lowered to $6 from $9 at Stifel